πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 68 of 200 Β· A–Z by INN

  1. erdafitinib

    BALVERSA

    ORAL FDA: approved Β· EMA: approved

    L01EN01
  2. erenumab

    AIMOVIG

    EMA: approved

    N02CD01
  3. erenumab-aooe

    AIMOVIG

    INJECTION FDA: approved

  4. ergocalciferol

    ERGOCALCIFEROL

    ORAL FDA: approved

  5. ergoloid mesylates

    GERIMAL

    ORAL FDA: approved

  6. ergotamine tartrate

    ERGOMAR

    INHALATION FDA: approved

  7. eribulin

    ERIBULIN DR.REDDY''S Eisai Co.,

    EMA: approved Β· TGA: approved

    L01XX41
  8. eribulin mesilate

    HALAVEN INITIAL APPROVAL

    PMDA: approved

  9. eribulin mesylate

    ERIBULIN MESYLATE

    INTRAVENOUS FDA: approved

  10. erlotinib

    ERLOTINIB ARX Lacuna Pharma Pty Ltd

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01EB02
  11. erlotinib hydrochloride

    ERLOTINIB HYDROCHLORIDE Teva Pharma GmbH

    ORAL FDA: approved

  12. ertapenem

    INVANZ

    EMA: approved

    J01DH03
  13. ertapenem sodium

    ERTAPENEM SODIUM

    INTRAMUSCULAR, INTRAVENOUS FDA: approved

  14. ertugliflozin

    SEGLUROMET

    ORAL FDA: approved Β· EMA: approved

    A10BK04
  15. erythromycin

    MAYNE PHARMA ERYTHROMYCIN Amneal Pharma Europe Ltd

    OPHTHALMIC FDA: approved Β· TGA: approved Β· NMPA: clinical trials

  16. erythromycin estolate

    ERYTHROMYCIN ESTOLATE Teva Pharma GmbH

    ORAL FDA: approved

  17. erythromycin ethylsuccinate

    E-MYCIN 200 Alphapharm Pty Ltd

    ORAL FDA: approved Β· TGA: approved

  18. erythromycin gluceptate

    ILOTYCIN GLUCEPTATE

    INJECTION FDA: approved

  19. erythromycin lactobionate

    ERYTHROMYCIN Teva Pharma GmbH

    INJECTION FDA: approved

  20. erythromycin stearate

    ERYTHROMYCIN STEARATE

    ORAL FDA: approved

  21. erythropoietin

    NMPA: clinical trials

  22. esaxerenone

    MINNEBRO

    PMDA: approved

  23. escalation

    NMPA: clinical trials

  24. escitalopram

    APO-ESCITALOPRAM Alphapharm Pty Ltd

    TGA: approved Β· NMPA: clinical trials

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources